Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial
Davangere P. Devanand, Elizabeth Crocco, Brent P. Forester, et al.
American Journal of Geriatric Psychiatry (2021) Vol. 30, Iss. 1, pp. 32-42
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities
Zahinoor Ismail, Byron Creese, Dag Aarsland, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 131-144
Open Access | Times Cited: 132
Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
Neha Basheer, Tomáš Smolek, Md. Imtaiyaz Hassan, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2197-2214
Open Access | Times Cited: 62
Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
Monique Patrício Singulani, Ana Flávia Fernandes Ferreira, Paulina Sepúlveda Figueroa, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102231-102231
Closed Access | Times Cited: 12
How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies
Stacey M. Fernandes, Johanna Mayer, Per Nilsson, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
Yanxin Shen, Meng Zhao, Panpan Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Lithium Content and Its Nutritional Beneficence, Dietary Intake, and Impact on Human Health in Edibles from the Romanian Market
Andreea Maria Iordache, Cezara Voica, Carmen Roba, et al.
Foods (2024) Vol. 13, Iss. 4, pp. 592-592
Open Access | Times Cited: 5
Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms
Gihwan Byeon, Dong Woo Kang, Yeshin Kim, et al.
Dementia and Neurocognitive Disorders (2025) Vol. 24, Iss. 1, pp. 24-24
Open Access
An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective
Márcia Radanovic, Monique Patrício Singulani, Vanessa de Jesus Rodrigues de Paula, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 532-532
Open Access
Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership
Antoinette B. Coe, Tingting Zhang, Andrew R. Zullo, et al.
Journal of the American Geriatrics Society (2022) Vol. 70, Iss. 12, pp. 3513-3525
Open Access | Times Cited: 18
Identifying the neuropsychiatric health effects of low-dose lithium interventions: A systematic review
Rebecca Strawbridge, Jess Kerr‐Gaffney, Giulia Bessa, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104975-104975
Open Access | Times Cited: 17
Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm
Jeffrey L. Cummings, Mary Sano, Stefanie Auer, et al.
International Psychogeriatrics (2023) Vol. 36, Iss. 4, pp. 251-262
Open Access | Times Cited: 10
Lithium and its effects: does dose matter?
Mirko Manchia, Pasquale Paribello, Martina Pinna, et al.
International Journal of Bipolar Disorders (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Lithium, a Treatment Option for Alzheimer’s Disease? A Review of Existing Evidence and Discussion on Future Perspectives
Solene Guilliot, Serge Gauthier, Jacques Touchon, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 2, pp. 473-482
Closed Access | Times Cited: 6
Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
Futao Zhou, Yushi Zhao, Yangyan Sun, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 11
Open Access | Times Cited: 2
Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer’s Disease
Camillo Imbimbo, Matteo Cotta Ramusino, Silvia Leone, et al.
CNS Drugs (2024)
Open Access | Times Cited: 2
Experimental data on lithium salts: From neuroprotection to multi-organ complications
Samaneh Kakhki, S. Mohammad Ahmadi‐Soleimani
Life Sciences (2022) Vol. 306, pp. 120811-120811
Closed Access | Times Cited: 10
Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review
Camilla Elefante, Giulio Emilio Brancati, S. Torrigiani, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 12, pp. 2516-2542
Closed Access | Times Cited: 9
Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research
Minghao Yuan, Yangyang Wang, Zhenting Huang, et al.
Journal of Biomedical Research (2022) Vol. 37, Iss. 1, pp. 30-30
Open Access | Times Cited: 9
Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome
Giulia Cencelli, G Pedini, Claudia Ricci, et al.
Neurobiology of Disease (2024) Vol. 203, pp. 106726-106726
Open Access | Times Cited: 1
Alzheimer’s Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment
Amira Yasmine Benmelouka, Yassamine Ouerdane, Oumaima Outani, et al.
Current Alzheimer Research (2022) Vol. 19, Iss. 4, pp. 285-301
Closed Access | Times Cited: 7
Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease
Nathan Herrmann, Hui Jue Wang, Bing Xin Song, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 10, pp. 1289-1301
Closed Access | Times Cited: 7
Neuropsychiatric Manifestations in Alzheimer’s Disease Patients: Genetics and Treatment Options
Arun Kumar Singh, Rishabha Malviya, Anuj Prakash, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 1, pp. 39-54
Closed Access | Times Cited: 3
Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review
Andreea L. Seritan
Journal of Geriatric Psychiatry and Neurology (2023) Vol. 36, Iss. 6, pp. 435-460
Open Access | Times Cited: 3
Fountain of youth—Targeting autophagy in aging
Lea Danics, A Abbas, Balázs Kis, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top